close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sonoma Biotherapeutics, Inc.

Sonoma Biotherapeutics Announces Upcoming Poster Presentation at the 10th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA)
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Announces Positive Interim Safety and Efficacy Data from Phase 1 REGULATE-RA Study of SBT-77-7101 in Refractory Rheumatoid Arthritis
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Announces Upcoming Late-Breaking Oral and Poster Presentations at the 2025 American College of Rheumatology (ACR) Convergence
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Congratulates Fred Ramsdell, PhD, Co-Founder and Scientific Advisory Board Chair, on Receiving the 2025 Nobel Prize in Physiology or Medicine...
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Appoints Lisa Taylor Ash, JD, as Chief Legal Officer
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Announces Poster Presentation at the 2025 European Alliance of Associations for Rheumatology (EULAR) Congress
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Receives $45 Million Milestone Payment from Regeneron under Ongoing Collaboration
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Therapy for Rheumatoid Arthritis at American College of Rheumatology Convergence 2023
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Cell Therapy at Symposium on Hidradenitis Suppurativa Advances
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Tickers REGN
Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Cell Therapy for Rheumatoid Arthritis at American College of Rheumatology Convergence 2022
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Appoints Jessica Stitt as Chief Financial Officer
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Enters Long-Term Lease Agreement to Establish a Treg Cell Therapy R&D and Manufacturing Center
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Sonoma Biotherapeutics Expands Board of Directors with Appointments of Katina Dorton, J.D., MBA, and John Davis, M.D., MPH
From Sonoma Biotherapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today